Eslicarbazepine: systemic exposure to antiepileptic drugs is increased in patients with mild-to-moderate renal impairment. The dose of eslicarbazepine should be reduced in patients with a ...

Generic drug substitution can markedly decrease the cost of health care. For conditions where agents have a relatively narrow therapeutic index, notably epilepsy, financial savings through generic ...

Dr. Collins brings extensive drug development and clinical expertise in epilepsy --NEW YORK and VANCOUVER, British Columbia, Jan. 07, 2025 ...

The newborn had a birth defect that left a gap in his lower spine, through which tissue pushed out and formed a giant, red, ...

Yale researchers identified an underactive mTOR pathway as a cause of lissencephaly and reversed brain malformations in ...

Lissencephaly is a spectrum of rare, genetic disorders in which the brain fails to develop its hallmark folds. The disorders are often associated with seizures and intellectual disability and ...

A kiosk holding the opioid antagonist Naloxone for free use in case of emergency in front of is seen Tuesday Mesa County ...

LUMRYZ, is an extended-release sodium oxybate medication approved by the FDA on May 1, 2023, as the first and only once-at-bedtime treatment for cataplexy or excessive daytime sleepiness (EDS) in ...

At the beginning of 2025, a suite of fifteen Washington bills became law, transforming key areas from health care to workers' ...

Lissencephaly refers to a rare condition in which the folds usually found in the brain do not develop, and brain development is disrupted. People with the | Clinical And Molecular Dx ...